Registered number
12435884
Spotlight Pathology Ltd
Unaudited Filleted Accounts
31 January 2023
Spotlight Pathology Ltd
Registered number: 12435884
Balance Sheet
as at 31 January 2023
Notes 2023 2022
£ £ £ £
Fixed assets
Tangible assets 3 1,945 1,166
Current assets
Debtors 4 80,474 22,431
Cash at bank and in hand 101,852 62,501
182,326 84,932
Creditors: amounts falling due within one year 5 (9,160) (97,551)
Net current assets/(liabilities) 173,166 (12,619)
Net assets/(liabilities) 175,111 (11,453)
Capital and reserves
Called up share capital 116 100
Share premium 242,635 -
Profit and loss account (67,640) (11,553)
Shareholders' funds 175,111 (11,453)
The directors are satisfied that the company is entitled to exemption from the requirement to obtain an audit under section 477 of the Companies Act 2006.
The members have not required the company to obtain an audit in accordance with section 476 of the Act.
The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts.
The accounts have been prepared and delivered in accordance with the special provisions applicable to companies subject to the small companies regime. The profit and loss account has not been delivered to the Registrar of Companies.
M P Fergie
Director
Approved by the board on 11 August 2023
Spotlight Pathology Ltd
Notes to the Accounts
for the year ended 31 January 2023
1 Accounting policies
Basis of preparation
The accounts have been prepared under the historical cost convention and in accordance with FRS 102, The Financial Reporting Standard applicable in the UK and Republic of Ireland (as applied to small entities by section 1A of the standard).
Turnover
Turnover is measured at the fair value of the consideration received or receivable, net of discounts and value added taxes. Turnover includes revenue earned from the sale of goods and from the rendering of services. Turnover from the sale of goods is recognised when the significant risks and rewards of ownership of the goods have transferred to the buyer. Turnover from the rendering of services is recognised by reference to the stage of completion of the contract. The stage of completion of a contract is measured by comparing the costs incurred for work performed to date to the total estimated contract costs.
Tangible fixed assets
Tangible fixed assets are measured at cost less accumulative depreciation and any accumulative impairment losses. Depreciation is provided on all tangible fixed assets, other than freehold land, at rates calculated to write off the cost, less estimated residual value, of each asset evenly over its expected useful life, as follows:
Equipment over 3 years
Debtors
Short term debtors are measured at transaction price (which is usually the invoice price), less any impairment losses for bad and doubtful debts. Loans and other financial assets are initially recognised at transaction price including any transaction costs and subsequently measured at amortised cost determined using the effective interest method, less any impairment losses for bad and doubtful debts.
Creditors
Short term creditors are measured at transaction price (which is usually the invoice price). Loans and other financial liabilities are initially recognised at transaction price net of any transaction costs and subsequently measured at amortised cost determined using the effective interest method.
Taxation
A current tax liability is recognised for the tax payable on the taxable profit of the current and past periods. A current tax asset is recognised in respect of a tax loss that can be carried back to recover tax paid in a previous period. Deferred tax is recognised in respect of all timing differences between the recognition of income and expenses in the financial statements and their inclusion in tax assessments. Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the reporting date and that are expected to apply to the reversal of the timing difference, except for revalued land and investment property where the tax rate that applies to the sale of the asset is used. Current and deferred tax assets and liabilities are not discounted.
Pensions
Contributions to defined contribution plans are expensed in the period to which they relate.
2 Employees 2023 2022
Number Number
Average number of persons employed by the company 3 3
3 Tangible fixed assets
Equipment
£
Cost
At 1 February 2022 1,749
Additions 2,043
At 31 January 2023 3,792
Depreciation
At 1 February 2022 583
Charge for the year 1,264
At 31 January 2023 1,847
Net book value
At 31 January 2023 1,945
At 31 January 2022 1,166
4 Debtors 2023 2022
£ £
Trade debtors 14,647 -
Grants 62,590 19,013
Other debtors 3,237 3,418
80,474 22,431
5 Creditors: amounts falling due within one year 2023 2022
£ £
Trade creditors 829 2,374
Taxation and social security costs 5,701 -
Accruals 1,970 2,793
Other creditors 660 92,384
9,160 97,551
6 Other information
Spotlight Pathology Ltd is a private company limited by shares and incorporated in England. Its registered office is:
C/o Umi3 Ctf,
46 Grafton Street
Manchester
M13 9NT
Spotlight Pathology Ltd 12435884 false 2022-02-01 2023-01-31 2023-01-31 VT Final Accounts October 2023 M P Fergie No description of principal activity 12435884 2021-02-01 2022-01-31 12435884 core:WithinOneYear 2022-01-31 12435884 core:ShareCapital 2022-01-31 12435884 core:SharePremium 2022-01-31 12435884 core:RetainedEarningsAccumulatedLosses 2022-01-31 12435884 2022-02-01 2023-01-31 12435884 bus:PrivateLimitedCompanyLtd 2022-02-01 2023-01-31 12435884 bus:AuditExemptWithAccountantsReport 2022-02-01 2023-01-31 12435884 bus:Director40 2022-02-01 2023-01-31 12435884 1 2022-02-01 2023-01-31 12435884 2 2022-02-01 2023-01-31 12435884 core:PlantMachinery 2022-02-01 2023-01-31 12435884 countries:England 2022-02-01 2023-01-31 12435884 bus:FRS102 2022-02-01 2023-01-31 12435884 bus:FullAccounts 2022-02-01 2023-01-31 12435884 2023-01-31 12435884 core:WithinOneYear 2023-01-31 12435884 core:ShareCapital 2023-01-31 12435884 core:SharePremium 2023-01-31 12435884 core:RetainedEarningsAccumulatedLosses 2023-01-31 12435884 core:PlantMachinery 2023-01-31 12435884 2022-01-31 12435884 core:PlantMachinery 2022-01-31 iso4217:GBP xbrli:pure